2020 Medical Patient-Centered Relationship 
Today's Hospitalist
MAY 9, 2025
But these early systems often struggled with complex medical terminology and the natural flow of conversation. For many of us, the emergence of medical scribes, both in-person and remote, provided a valuable solution, offloading documentation and allowing us to have more focused patient interactions. The result?
The Clinical Problem Solvers
OCTOBER 18, 2022
Milburn Smith Child Health Research, Outreach, and Advocacy Center at the Ann & Robert H. All healthcare professionals will have patients who are directly or indirectly impacted by the carceral system. People who are incarcerated are dehumanized and feel they are treated as inmates, rather than as patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
JULY 7, 2021
Gibbs — In the first challenge ever brought against FDA’s rarely used power to ban a medical device, a court found FDA overstepped its authority and overturned the ban. The use of GEDs by JRC is subject to extensive regulation by Massachusetts, including the need for a judge to authorize the treatment for any patient.
The Clinical Problem Solvers
AUGUST 25, 2020
Trainees may use this foundation to question how this might impact their medical education and think about this educational legacy may be reformed through curricular and structural changes at their institutions. It impacts the health of our colleagues who constantly have to witness this injustice play on television, often without consequence.
FDA Law Blog
OCTOBER 10, 2023
Dr. Beitz served in leadership positions in FDA’s Center for Drug Evaluation and Research for nearly three decades. Dr. Beitz was selected by FDA to be the inaugural Director of OII in March 2020 as part of the CDER OND reorganization. (“HP&M”), the largest FDA-dedicated law firm, is pleased to announce that Julie Beitz, M.D.
FDA Law Blog
JUNE 23, 2021
Valentine — For the last 13 years, this blogger has been at the center of what has now been dubbed “patient-focused drug development.” For 6 years, I served as a patient liaison within FDA in what was then called the Office of Special Health Issues. By James E.
GeriPal
JUNE 8, 2023
When I’m on palliative care consults and attending in our hospice unit we have to counsel patients about deprescribing and de-intensifying diabetes medications. What are the risks and rewards of new classes of medications? When I’m on nursing home call, the most common page I receive is for a blood sugar value. Happy to be here.
Expert insights. Personalized for you.
52 
Let's personalize your content